dd, Jϭ13.0, 2.6 Hz) were corresponding to the protons, H-2, H-3/ H-2Љ, H-3Љ of two flavanone moieties, respectively. Three methoxyl protons at d H 3.81 (3H, s), 3 .80 (3H, s), and 3.75 (3H, s) were assigned at C-4Ј, C-7, and C-7Љ, respectively, according to the three-bond heteronuclear multiple bond connectivity (HMBC) connectivities with the carbon signals at dc 158.2, 170.0, and 165.4, respectively. Two meta-coupled aromatic proton signals at H-6 and H-8 appeared at d H 6.06 and 6.05 (Jϭ2.6 Hz). The A 2 X 2 coupling system was established from the signals at d H 6.90 (2H, d, Jϭ8.2 Hz, H-3ٞ, 5ٞ) and 7.36 (2H, d, Jϭ8.2 Hz, H-2ٞ, 6ٞ). The HMBC correlations of C-6Љ/OH-5Љ, H-2Ј, H-8Љ and C-3Ј/H-5Ј, H-8Љ indicated that 1 had an interflavonoid linkage between C-3Ј and C-6Љ corresponding to its biflavonoid skeleton of robustaflavone series. 1, 4, 8) The 1 H-and 13 C-NMR signals of 1 were assigned unambiguously by further detailed analysis of the 1 H-13 C HSQC, 1 H-13 C HMBC, and 1 H-1 H correlative spectroscopy (COSY) spectra as shown in Fig. 1 .
To resolve the absolute configuration at C-2 and C-2Љ of 1, the circular dichroism (CD) experiment was performed. The CD spectrum of 1 exhibited a positive cotton effect at 328 nm and a negative cotton effect at 290 nm, respectively, indicating the typical "S" configuration at C-2 in flavanone skeleton. 9) Therefore, the structure of 1 was determined as a new biflavanone, 2,2Љ,3,3Љ-tetrahydrorobustaflavone 7,4Ј,7Љtrimethyl ether. Compounds 2 and 3 were identified as the known biflavonoids, robustaflavone 7,4Ј,7Љ-trimethyl ether 8) and robustaflavone 4Ј-methyl ether, 1, 4) respectively.
Compounds 1 (IC 50 19.1, 23.5, 28.8 mM) and 2 (IC 50 15.6, 20.1, 22.5 mM) exhibited cytotoxic activity against the three human cancer cell lines, HCT116, NCI-H358, and K562, whereas compound 3 did not show activity. Compounds 1 and 2 have methoxyls at C-7 and C-7Љ in their flavonoid skeleton, whereas compound 3 has hydroxyls at C-7 and C-7Љ, indicating the methoxyls at C-7 and C-7Љ seem to be important for their cytotoxic activity, although further studies are needed.
Experimental
General Optical rotations were measured with a P-1010 polarimeter (JASCO, Japan) at 25°C. UV spectra (l max ) were recorded on a U-3000 spectrophotometer (Hitachi, Japan). IR spectra (n max ) were determined on a FTS 135 FT-IR spectrometer (Bio-Rad, CA, U.S.A.). Circular dichroism measurements were performed using JASCO J-715 CD/ORD spectropolarimeter. The 1D and 2D NMR experiments were conducted on a UNITY INOVA 400 MHz FT-NMR (varian, CA, U.S.A.), and TMS was used as an internal standard. ESI-MS, HR-ESI-MS and FAB-MS were obtained on a JMS 700 Mastation HR-MS spectrometer (JEOL, Japan). TLC analysis was performed on Kieselgel 60 F 254 (Merck, Germany) plates (silica gel, 0.25 mm layer thickness), with compounds visualized by dipping plates into 10% (v/v) H 2 SO 4 reagent (Aldrich) followed by charring at 110°C for 5-10 min. Silica gel (230-400 mesh, Merck, Germany), and RP-18 (YM-CGEL ODS-A, 12 nm, S-150 mm) were used for column chromatography. All solvents used for chromatographic separations were distilled before use.
Plant Material The whole plants of S. doedeleinii HIERON. were collected at Batu Medica Centre, East Java, Indonesia, in May 2005 and were identified by Prof. Adam Wiryawan (Brawijaya University, Malang 65145, Indonesia). A voucher specimen has been deposited at the Batu Herba Medica Centre.
Extraction and Isolation The dried and milled plant material (335 g) was extracted with MeOH (3ϫ8 l) by maceration. The MeOH extracts (25 g) were separated by liquid column chromatograph [(glass column (6.4ϫ22 cm); silica gel (230-400 mesh, 360 g)] using gradient mixtures of n-hexane-EtOAc-MeOH gradients (from n-hexane-EtOAcϭ49 : 1 to 1 : 1, n-hexane-EtOAc-MeOHϭ1 : 1 : 0 to 0 : 0 : 1) as mobile phases to give 13 fractions (FI-FXIII). Fraction FXII (7.5 g, n-hexane-EtOAc-MeOHϭ 1 : 1 : 5) was subjected to Sephadex LH-20 column chromatography using 100% MeOH as a solvent system (F01-F05). The F01 fraction (15 mg) was chromatographed over reverse-phase column (f 2.2 cm; ODS-A, 12 nm, S-150 mm, 40 g) with MeOH-H 2 O gradient (from 6 : 4 to 8 : 2 v/v), giving 1 (2.1 mg, 0.00039% w/w). F02 (90.1 mg) was eluted with MeOH-H 2 O (f 2.2 cm; ODS-A, 12 nm, S-150 mm, 40 g) by reverse-phase column chromatography, providing 5 fractions (F0201-F0205). Subfraction, F0205 (30.5 mg) was further separated using a preparative TLC (CHCl 3 -MeOHϭ 49 : 1) to afford compound 2 (3 mg, 0.00056%, Rf 0.25). F05 fraction (1.1 g) was further fractionated by flash silica gel column chromatography (f 2.8 cm; 230-400 mesh, 70 g) using CHCl 3 (1), 521 (1), 491 (1); 1 H-and 13 C-NMR data were in agreement with reported values. 1, 4) In Vitro Cytotoxicity Assay Cytotoxic potential was determined as described previously. 11) Briefly, cells (in log growth phase) were counted, diluted to 5ϫ10 4 cells/ml with fresh medium, and added to 96-well microtiter plates (190 ml/well) containing test materials (10 ml in 10% aqueous DMSO). Test plates were incubated for 3 d at 37°C in CO 2 incubator. All treatments were performed in triplicate. After the incubation periods, cells were fixed by the addition of 50 mM of cold 50% aqueous trichloroacetic acid (4°C for 30 min), washed 4-5 times with tap water, and air-dried. The fixed cells were stained with sulforhodamine B (SRB) (0.4% w/w SRB in 1% aqueous acetic acid) for 30 min. Free SRB solution was then air-dried, the bound dye was solubilized with 200 ml of 10 mM tris-base (pH 10.0), and absorbance was determined at 515 nm using an ELISA plate reader. Finally, the absorbance values obtained with each of the treatment procedures were averaged, and the averaged value obtained with the zero day control was subtracted. These results were expressed as a percentage, relative to solventtreated control incubations, and EC 50 values were calculated using non-linear regression analyses (percent survival versus concentration). Ellipticine was used as a positive control.
